Casey Woodring
Stock Analyst at JP Morgan
(0.27)
# 4,110
Out of 4,853 analysts
33
Total ratings
15%
Success rate
-22.06%
Average return
Main Sectors:
Stocks Rated by Casey Woodring
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ICLR ICON Public Limited Company | Downgrades: Neutral | $265 → $150 | $134.82 | +11.26% | 6 | Apr 29, 2025 | |
| QDEL QuidelOrtho | Maintains: Underweight | $38 → $25 | $29.90 | -16.39% | 4 | Apr 21, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $175 → $165 | $141.20 | +16.86% | 7 | Feb 20, 2025 | |
| HOLX Hologic | Maintains: Overweight | $92 → $94 | $63.07 | +49.04% | 5 | Nov 5, 2024 | |
| QGEN Qiagen | Maintains: Overweight | $54 → $56 | $45.56 | +22.08% | 4 | Jun 18, 2024 | |
| OSUR OraSure Technologies | Maintains: Neutral | $7 → $6 | $2.81 | +113.52% | 3 | May 13, 2024 | |
| EGBN Eagle Bancorp | Maintains: Neutral | $25 → $23 | $16.82 | +36.74% | 2 | Oct 31, 2023 | |
| SHC Sotera Health Company | Upgrades: Neutral | $6 → $18 | $12.19 | +47.66% | 2 | Jan 23, 2023 |
ICON Public Limited Company
Apr 29, 2025
Downgrades: Neutral
Price Target: $265 → $150
Current: $134.82
Upside: +11.26%
QuidelOrtho
Apr 21, 2025
Maintains: Underweight
Price Target: $38 → $25
Current: $29.90
Upside: -16.39%
Charles River Laboratories International
Feb 20, 2025
Maintains: Neutral
Price Target: $175 → $165
Current: $141.20
Upside: +16.86%
Hologic
Nov 5, 2024
Maintains: Overweight
Price Target: $92 → $94
Current: $63.07
Upside: +49.04%
Qiagen
Jun 18, 2024
Maintains: Overweight
Price Target: $54 → $56
Current: $45.56
Upside: +22.08%
OraSure Technologies
May 13, 2024
Maintains: Neutral
Price Target: $7 → $6
Current: $2.81
Upside: +113.52%
Eagle Bancorp
Oct 31, 2023
Maintains: Neutral
Price Target: $25 → $23
Current: $16.82
Upside: +36.74%
Sotera Health Company
Jan 23, 2023
Upgrades: Neutral
Price Target: $6 → $18
Current: $12.19
Upside: +47.66%